These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 19699855)

  • 41. Medication Adherence Does Not Explain Black-White Differences in Cardiometabolic Risk Factor Control among Insured Patients with Diabetes.
    Lafata JE; Karter AJ; O'Connor PJ; Morris H; Schmittdiel JA; Ratliff S; Newton KM; Raebel MA; Pathak RD; Thomas A; Butler MG; Reynolds K; Waitzfelder B; Steiner JF
    J Gen Intern Med; 2016 Feb; 31(2):188-195. PubMed ID: 26282954
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Adverse differences in cardiometabolic risk factor levels between individuals with pre-diabetes and normal glucose metabolism are more pronounced in women than in men: the Maastricht Study.
    de Ritter R; Sep SJS; van der Kallen CJH; Schram MT; Koster A; Kroon AA; van Greevenbroek MMJ; Eussen SJPM; Dagnelie PC; de Jong M; Vos RC; Woodward M; Bots ML; Peters SAE; Stehouwer CDA
    BMJ Open Diabetes Res Care; 2019; 7(1):e000787. PubMed ID: 31798903
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Electronic messaging intervention for management of cardiovascular risk factors in type 2 diabetes mellitus: A randomised controlled trial.
    Fang R; Deng X
    J Clin Nurs; 2018 Feb; 27(3-4):612-620. PubMed ID: 28700102
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A randomized trial of a primary care-based disease management program to improve cardiovascular risk factors and glycated hemoglobin levels in patients with diabetes.
    Rothman RL; Malone R; Bryant B; Shintani AK; Crigler B; Dewalt DA; Dittus RS; Weinberger M; Pignone MP
    Am J Med; 2005 Mar; 118(3):276-84. PubMed ID: 15745726
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Metabolic syndrome in nondiabetic, obese, first-degree relatives of African American patients with type 2 diabetes: African American triglycerides-HDL-C and insulin resistance paradox.
    Meis SB; Schuster D; Gaillard T; Osei K
    Ethn Dis; 2006; 16(4):830-6. PubMed ID: 17061734
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Reduction of cardiovascular risk factors in subjects with type 2 diabetes by Pycnogenol supplementation.
    Zibadi S; Rohdewald PJ; Park D; Watson RR
    Nutr Res; 2008 May; 28(5):315-20. PubMed ID: 19083426
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Telemedicine cardiovascular risk reduction in veterans: The CITIES trial.
    Bosworth HB; Olsen MK; McCant F; Stechuchak KM; Danus S; Crowley MJ; Goldstein KM; Zullig LL; Oddone EZ
    Am Heart J; 2018 May; 199():122-129. PubMed ID: 29754649
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Changes in body mass index, glycosylated hemoglobin A1C, blood pressure, and LDL-cholesterol among type 2 diabetes patients in Malaysia: A population-based longitudinal study.
    Wan KS; Moy FM; Mustapha FI; Ismail M; Hairi NN
    J Diabetes; 2021 Nov; 13(11):915-929. PubMed ID: 34142456
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Telephone-Delivered Behavioral Skills Intervention for African American Adults with Type 2 Diabetes: A Randomized Controlled Trial.
    Egede LE; Williams JS; Voronca DC; Gebregziabher M; Lynch CP
    J Gen Intern Med; 2017 Jul; 32(7):775-782. PubMed ID: 28337686
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of a nurse-led lifestyle choice and coaching intervention on systolic blood pressure among type 2 diabetic patients with a high atherosclerotic cardiovascular risk: study protocol for a cluster-randomized trial.
    Lumu W; Kibirige D; Wesonga R; Bahendeka S
    Trials; 2021 Feb; 22(1):133. PubMed ID: 33573687
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Primacy of the 3B approach to control risk factors for cardiovascular disease in type 2 diabetes patients.
    Ji L; Hu D; Pan C; Weng J; Huo Y; Ma C; Mu Y; Hao C; Ji Q; Ran X; Su B; Zhuo H; Fox KA; Weber M; Zhang D; ;
    Am J Med; 2013 Oct; 126(10):925.e11-22. PubMed ID: 23810406
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A randomized controlled trial of weight reduction and exercise for diabetes management in older African-American subjects.
    Agurs-Collins TD; Kumanyika SK; Ten Have TR; Adams-Campbell LL
    Diabetes Care; 1997 Oct; 20(10):1503-11. PubMed ID: 9314625
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of multidisciplinary intensive targeted care in improving diabetes mellitus outcomes: a randomized controlled pilot study - the Integrated Diabetes Education, Awareness and Lifestyle modification in Singapore (IDEALS) Program.
    Tan E; Khoo J; Gani LU; Malakar RD; Tay TL; Tirukonda PS; Kam JW; Tin AS; Tang TY
    Trials; 2019 Sep; 20(1):549. PubMed ID: 31477163
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cultural competency training and performance reports to improve diabetes care for black patients: a cluster randomized, controlled trial.
    Sequist TD; Fitzmaurice GM; Marshall R; Shaykevich S; Marston A; Safran DG; Ayanian JZ
    Ann Intern Med; 2010 Jan; 152(1):40-6. PubMed ID: 20048271
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Racial and ethnic disparities in the control of cardiovascular disease risk factors in Southwest American veterans with type 2 diabetes: the Diabetes Outcomes in Veterans Study.
    Wendel CS; Shah JH; Duckworth WC; Hoffman RM; Mohler MJ; Murata GH
    BMC Health Serv Res; 2006 May; 6():58. PubMed ID: 16716235
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Meaning of Illness and Cardiovascular Risk Factors in Patients With Type 2 Diabetes.
    Lynch CP; Strom Williams J; Voronca D; Walker RJ; Egede LE
    Diabetes Educ; 2016 Apr; 42(2):220-7. PubMed ID: 26879460
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Identifying risk factors for racial disparities in diabetes outcomes: the translating research into action for diabetes study.
    Duru OK; Gerzoff RB; Selby JV; Brown AF; Ackermann RT; Karter AJ; Ross S; Steers N; Herman WH; Waitzfelder B; Mangione CM
    Med Care; 2009 Jun; 47(6):700-6. PubMed ID: 19480090
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The effectiveness of peer health coaching in improving glycemic control among low-income patients with diabetes: protocol for a randomized controlled trial.
    Ghorob A; Vivas MM; De Vore D; Ngo V; Bodenheimer T; Chen E; Thom DH
    BMC Public Health; 2011 Apr; 11():208. PubMed ID: 21457567
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Renal Disease Risk Factors Among Risk Groups Comprised of African American Women With Type 2 Diabetes: A Secondary Analysis.
    Migliore CL; Vorderstrasse A; Pan W; Melkus GD
    Diabetes Educ; 2015 Oct; 41(5):569-81. PubMed ID: 26202051
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Impact of low-density lipoprotein cholesterol on cardiovascular outcomes in people with type 2 diabetes: a meta-analysis of prospective cohort studies.
    Wang Y; Lammi-Keefe CJ; Hou L; Hu G
    Diabetes Res Clin Pract; 2013 Oct; 102(1):65-75. PubMed ID: 23932206
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.